key: cord-0969705-wdgom8lj
authors: Norsa, Lorenzo
title: Reply to letter: “Intestinal ischemic manifestations of COVID 19” from Pr. Antonio Ponzetto
date: 2021-01-21
journal: Gastroenterology
DOI: 10.1053/j.gastro.2021.01.197
sha: 8840c89a1c5928c87d2733c35ce08a757feedebc
doc_id: 969705
cord_uid: wdgom8lj

nan

Dear editors, we are extremely grateful for the interest of Pr. Ponzetto for our manuscript and would like to take the opportunity to answer his very interesting comments.

The possible association of Helicobacter Pylori with intestinal ischemic manifestations of severe acute respiratory syndrome-2 (SARS-CoV-2) sounds really intriguing. Unfortunately, since all the analysis was performed during an important sanitary emergency in Lombardy 1 none of the patients was tested for possible coinfections.

We would also like to emphasised that the strong tropism of SARS-CoV-2 for the gastrointestinal 

COVID-19 and Italy: what next?

Evidence for Gastrointestinal Infection of SARS-CoV-2

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab

Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury

Induction of intestinal ischemia reperfusion injury by portal vein outflow occlusion in rats